title: How economics can shape precision medicines.
authors.affiliation: Harvard Business School, Boston, MA 02163, USA. astern@hbs.edu.|Ariadne Labs at Brigham and Women's Hospital and the Harvard T. H. Chan School of Public Health, Boston, MA 02215, USA.
authors.forename: A D
authors.initials: AD
authors.lastname: Stern
authors.affiliation: Dana-Farber Cancer Institute, Boston, MA 02215, USA.|Harvard Program in Therapeutic Science, Harvard Medical School, Boston, MA 02115, USA.
authors.forename: B M
authors.initials: BM
authors.lastname: Alexander
authors.affiliation: Harvard Business School, Boston, MA 02163, USA.|Harvard Kennedy School, Cambridge, MA 02138, USA.|National Bureau of Economic Research, Cambridge, MA 02138, USA.
authors.forename: A
authors.initials: A
authors.lastname: Chandra
mesh_terms: D015415:Biomarkers; D003365:Costs and Cost Analysis; D004467:Economics; D006297:Health Services Accessibility; D006801:Humans; D009965:Orphan Drug Production / Q000191:economics; D057285:Precision Medicine / Q000191:economics*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D015415:Biomarkers